Table 4 Demographic profile of patients for stages 1 and 2
Treatment Groups | ||
|---|---|---|
Stage 1 N = 8 | Stage 2 N = 26 | |
Age (years) | ||
Mean ± SD | 34 ± 9 | 35 ± 9 |
Median | 37.0 | 33.0 |
Range | 21–44 | 22–55 |
Groups | n (%) | n (%) |
< 18 | 0 (0%) | 0 (0%) |
18 – 40 | 5 (62.5%) | 19 (73.1%) |
40 – 64 | 3 (37.5%) | 7 (26.9%) |
65 – 75 | 0 (0%) | 0 (0%) |
> 75 | 0 (0%) | 0 (0%) |
Sex | ||
Female | 0 (0%) | 19 (73.1%) |
Male | 8 (100) | 7 (26.9%) |
Race | ||
Asian | 1 (12.5%) | 0 (0%) |
Black | 1 (12.5%) | 4 (15.4%) |
Caucasian | 6 (75.0%) | 22 (84.6%) |
Other | 0 (0%) | 0 (0%) |
Weight (kg) | ||
Mean ± SD | 74.6 ± 10.7 | 64.0 ± 11.6 |
Median | 76.9 | 61.30 |
Range | 57.7–92.8 | 48.4–98.0 |
Height (cm) | ||
Mean ± SD | 175.3 ± 10.1 | 164.1 ± 9.8 |
Median | 175.25 | 161.25 |
Range | 158.5–189.0 | 149.0–189.0 |
Body Mass Index (kg/m2) | ||
Mean ± SD | 24.29 ± 2.72 | 23.63 ± 2.28 |
Median | 24.77 | 23.39 |
Range | 19.79–27.97 | 20.15–28.29 |